Literature DB >> 10520629

Diagnosing dementia with Lewy bodies.

I G McKeith1, J T O'Brien, C Ballard.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10520629     DOI： 10.1016/S0140-6736(99)90214-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Pentagon copying is more impaired in dementia with Lewy bodies than in Alzheimer's disease.

Authors:  T A Ala; L F Hughes; G A Kyrouac; M W Ghobrial; R J Elble
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-04       Impact factor: 10.154

2.  Dementia with Lewy bodies according to the consensus criteria in a general population aged 75 years or older.

Authors:  T Rahkonen; U Eloniemi-Sulkava; S Rissanen; A Vatanen; P Viramo; R Sulkava
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-06       Impact factor: 10.154

3.  The organization of narrative discourse in Lewy body spectrum disorder.

Authors:  Sharon Ash; Corey McMillan; Rachel G Gross; Philip Cook; Brianna Morgan; Ashley Boller; Michael Dreyfuss; Andrew Siderowf; Murray Grossman
Journal:  Brain Lang       Date:  2011-10       Impact factor: 2.381

4.  Diffuse Lewy Body Disease.

Authors:  Theresa A. Zesiewicz; Matthew J. Baker; Peter B. Dunne; Robert A. Hauser
Journal:  Curr Treat Options Neurol       Date:  2001-11       Impact factor: 3.598

5.  Impairments of speech fluency in Lewy body spectrum disorder.

Authors:  Sharon Ash; Corey McMillan; Rachel G Gross; Philip Cook; Delani Gunawardena; Brianna Morgan; Ashley Boller; Andrew Siderowf; Murray Grossman
Journal:  Brain Lang       Date:  2011-11-17       Impact factor: 2.381

Review 6.  Neuropsychiatric symptoms in patients with dementias associated with cortical Lewy bodies: pathophysiology, clinical features, and pharmacological management.

Authors:  Clive Ballard; Dag Aarsland; Paul Francis; Anne Corbett
Journal:  Drugs Aging       Date:  2013-08       Impact factor: 3.923

Review 7.  Benefit-risk considerations in the treatment of dementia with Lewy bodies.

Authors:  Margaret M Swanberg; Jeffrey L Cummings
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

8.  Positive FP-CIT SPECT (DaTSCAN) in Clinical Alzheimer's Disease - An Unexpected Finding?

Authors:  Verena Bittner; Gerhard Ullrich; Markus Thormann; Notger G Müller; Christin Friederichs; Holger Amthauer; Hans-Jochen Heinze; Daniel M Bittner
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2011-09-21

Review 9.  Correlation Between Donepezil and QTc Prolongation and Torsades de Pointes: A Very Rare Phenomenon.

Authors:  Bilal Haider Malik; Pousette Hamid; Safeera Khan; Deepti Gupta; Muhammad Islam
Journal:  Cureus       Date:  2019-12-23

10.  Is ioflupane I123 injection diagnostically effective in patients with movement disorders and dementia? Pooled analysis of four clinical trials.

Authors:  John T O'Brien; Wolfgang H Oertel; Ian G McKeith; Donald G Grosset; Zuzana Walker; Klaus Tatsch; Eduardo Tolosa; Paul F Sherwin; Igor D Grachev
Journal:  BMJ Open       Date:  2014-07-03       Impact factor: 2.692
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.